Home/Filings/4/0001562180-25-000437
4//SEC Filing

Greene Barry E 4

Accession 0001562180-25-000437

CIK 0001597553other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:11 PM ET

Size

7.6 KB

Accession

0001562180-25-000437

Insider Transaction Report

Form 4
Period: 2025-01-16
Greene Barry E
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-01-16+174,000174,000 total
    Exercise: $6.97Exp: 2035-01-16Common Stock (174,000 underlying)
Footnotes (1)
  • [F1]The securities awarded on January 16, 2025 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. Options to purchase 43,500 shares of common stock shall vest on the one year anniversary of January 16, 2025, with 130,500 shares vesting in 36 equal monthly installments thereafter.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001291963

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:11 PM ET
Size
7.6 KB